BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21483005)

  • 1. Advanced insights into the biology of malignant lymphomas.
    Fisher RI
    J Clin Oncol; 2011 May; 29(14):1799-800. PubMed ID: 21483005
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers in malignant lymphomas and myeloma.
    Martinsson U
    Scand J Clin Lab Invest Suppl; 1991; 206():71-8. PubMed ID: 1947762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon-alpha in therapy of malignant hemoblastoses].
    Schuler M; Aulitzky WE; Schneller F; Peschel C; Huber C
    Internist (Berl); 1995 Dec; 36(12):1133-8. PubMed ID: 8567218
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
    Wagstaff J; Scarffe JH; Crowther D
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
    [No Abstract]   [Full Text] [Related]  

  • 5. [WHO-classification of malignant lymphomas].
    Rüdiger T; Müller-Hermelink HK
    Radiologe; 2002 Dec; 42(12):936-42. PubMed ID: 12486547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Lymphoma & Myeloma . . . and leukemia too!
    Cortés JE
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):344. PubMed ID: 19858052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of malignant hematological diseases].
    SANCHEZ MEDAL L
    Gac Med Mex; 1953; 83(6):443-51. PubMed ID: 13151339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hematologic diseases with alpha interferon].
    Castaigne S
    Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of environmental factors for etiology of leukemias, myelomas and malignant lymphomas].
    Brandt L
    Lakartidningen; 1982 Apr; 79(15):1490-2. PubMed ID: 7098650
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic outcomes in systemic lymphatic diseases and plasmacytoma. New hope for palliative patients].
    Heinrich B
    MMW Fortschr Med; 2005 Jun; 147(24):23. PubMed ID: 16001528
    [No Abstract]   [Full Text] [Related]  

  • 11. Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma.
    Adam M; Benbunan M; Fermand JP; Gisselbrecht C; Sitthy X; Maréchal B; Marchix T; Gerota J
    Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():33-4. PubMed ID: 1969307
    [No Abstract]   [Full Text] [Related]  

  • 12. Care of the patient with malignant lymphoma.
    Hays K; Rafferty DC
    Nurs Clin North Am; 1982 Dec; 17(4):677-95. PubMed ID: 6817308
    [No Abstract]   [Full Text] [Related]  

  • 13. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
    Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
    Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in the incidence and outcomes for patients with hematological malignancies.
    Flowers CR; Glover R; Lonial S; Brawley OW
    Curr Probl Cancer; 2007; 31(3):182-201. PubMed ID: 17543947
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical practice guidelines for malignant lymphomas].
    Hotta T
    Rinsho Ketsueki; 2004 Jun; 45(6):436-42. PubMed ID: 15287517
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
    Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
    Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Second neoplasms in malignant hematologic disorders. Experience from 1978 to 1987].
    Cristoffanini A; Zapata C; León A; Salas P
    Rev Med Chil; 1990 May; 118(5):522-9. PubMed ID: 2293272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the biology and treatment of pediatric lymphomas: Clues from international studies.
    Hochberg J; Cairo MS
    Pediatr Blood Cancer; 2009 Feb; 52(2):153-4. PubMed ID: 19034906
    [No Abstract]   [Full Text] [Related]  

  • 19. [Malignant lymphomas--the end of a long dispute?].
    Borisch B
    Rev Med Suisse Romande; 1999 Oct; 119(10):769-73. PubMed ID: 10582487
    [No Abstract]   [Full Text] [Related]  

  • 20. A decade of clinical lymphoma, myeloma & leukemia.
    Allen D
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):409. PubMed ID: 21156458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.